Previous 10 | Next 10 |
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
IRVINE, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its manage...
IRVINE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced strongly positiv...
Inari Medical (NARI) reports Q4 prelim net sales expected to be in the range of $47.9M-48.9M, an increase of 141% to 146% Y/Y and 24% to 26% increase Q/Q, exceeding guidance of $38.49M.During the 4Q, the company has completed ~4,600 procedures (+156% Y/Y) and (+24% Q/Q).Shares are&...
IRVINE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaud...
Medical device maker Inari Medical (NARI) receives 510(k) clearance from the FDA for its FlowTriever system for the treatment of clot in transit in the right atrium.FlowTriever is the first thrombectomy system not requiring a cardiopulmonary bypass circuit to be FDA cleared for bloo...
IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced U.S. Food and Dr...
IRVINE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointments...
The following slide deck was published by Inari Medical, Inc. in conjunction with this event. For further details see: Inari Medica (NARI) Investor Presentation - Slideshow
Inari Medical continues to live up to expectations, showing very solid growth and strong margins. I like the business a lot, yet have not initiated a position yet. While I am running behind the facts, I continue to like the company a lot, wishing for a pullback providing a solid e...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...